GSK Net Income 2010-2022 | GSK

GSK annual/quarterly net income history and growth rate from 2010 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • GSK net income for the quarter ending September 30, 2022 was $12.149B, a 654.34% increase year-over-year.
  • GSK net income for the twelve months ending September 30, 2022 was $16.609B, a 176.72% increase year-over-year.
  • GSK annual net income for 2021 was $6.03B, a 18.31% decline from 2020.
  • GSK annual net income for 2020 was $7.382B, a 24.46% increase from 2019.
  • GSK annual net income for 2019 was $5.931B, a 22.65% increase from 2018.
GSK Annual Net Income
(Millions of US $)
2021 $6,030
2020 $7,382
2019 $5,931
2018 $4,836
2017 $1,974
2016 $1,236
2015 $12,877
2014 $4,666
2013 $8,807
2012 $7,520
2011 $8,757
2010 $2,865
2009 $8,877
GSK Quarterly Net Income
(Millions of US $)
2022-09-30 $12,149
2022-06-30 $1,052
2022-03-31 $2,418
2021-12-31 $990
2021-09-30 $1,611
2021-06-30 $1,950
2021-03-31 $1,480
2020-12-31 $962
2020-09-30 $1,607
2020-06-30 $2,808
2020-03-31 $2,005
2019-12-31 $1,697
2019-09-30 $1,914
2019-06-30 $1,239
2019-03-31 $1,081
2018-12-31 $1,325
2018-09-30 $1,848
2018-06-30 $600
2018-03-31 $1,063
2017-12-31 $-678
2017-09-30 $1,587
2017-06-30 $-230
2017-03-31 $1,296
2016-12-31 $319
2016-09-30 $1,061
2016-06-30 $-624
2016-03-31 $404
2015-12-31 $-541
2015-09-30 $834
2015-06-30 $228
2015-03-31 $12,248
2014-12-31 $1,556
2014-09-30 $648
2014-06-30 $1,114
2014-03-31 $1,123
2013-12-31 $3,924
2013-09-30 $1,566
2013-06-30 $1,605
2013-03-31 $1,466
2012-12-31 $1,370
2012-09-30 $1,807
2012-06-30 $1,981
2012-03-31 $2,139
2011-12-31 $1,972
2011-09-30 $2,191
2011-06-30 $1,802
2011-03-31 $2,442
2010-12-31 $-1,116
2010-09-30 $2,082
2010-06-30 $-427
2010-03-31 $2,056
2009-12-31 $2,724
2009-09-30 $2,251
2009-06-30 $2,262
2009-03-31 $1,681
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $68.515B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $168.264B 10.27
Bio-Rad Laboratories (BIO.B) United States $11.666B 27.68
QIAGEN (QGEN) Netherlands $11.104B 18.95
Ginkgo Bioworks Holdings (DNA) United States $3.534B 0.00
Myovant Sciences (MYOV) United Kingdom $2.599B 0.00
Arcus Biosciences (RCUS) United States $1.967B 29.53
Biohaven (BHVN) United States $1.050B 0.00
Emergent Biosolutions (EBS) United States $0.590B 4.64
Zymeworks (ZYME) Canada $0.506B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.282B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.077B 0.00
Gelesis Holdings (GLS) United States $0.030B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00